Bianchi E - Search Results

1

Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.

Salvi S, Casadio V, Conteduca V, Burgio SL, Menna C, Bianchi E, Rossi L, Carretta E, Masini C, Amadori D, Calistri D, Attard G, De Giorgi U. Salvi S, et al. Among authors: bianchi e. Br J Cancer. 2015 May 12;112(10):1717-24. doi: 10.1038/bjc.2015.128. Epub 2015 Apr 21. Br J Cancer. 2015. PMID: 25897673 Free PMC article.

2

Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone.

Burgio SL, Conteduca V, Menna C, Carretta E, Rossi L, Bianchi E, Kopf B, Fabbri F, Amadori D, De Giorgi U. Burgio SL, et al. Among authors: bianchi e. Endocr Relat Cancer. 2014 May 8;21(3):487-93. doi: 10.1530/ERC-14-0071. Print 2014 Jun. Endocr Relat Cancer. 2014. PMID: 24741024

3

PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer.

Burgio SL, Conteduca V, Rudnas B, Carrozza F, Campadelli E, Bianchi E, Fabbri P, Montanari M, Carretta E, Menna C, De Giorgi U. Burgio SL, et al. Among authors: bianchi e. Clin Genitourin Cancer. 2015 Feb;13(1):39-43. doi: 10.1016/j.clgc.2014.06.010. Epub 2014 Jun 12. Clin Genitourin Cancer. 2015. PMID: 24999168

4

Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide.

Conteduca V, Burgio SL, Menna C, Carretta E, Rossi L, Bianchi E, Masini C, Amadori D, De Giorgi U. Conteduca V, et al. Among authors: bianchi e. Prostate. 2014 Dec;74(16):1691-6. doi: 10.1002/pros.22890. Epub 2014 Sep 27. Prostate. 2014. PMID: 25262981

5

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone.

De Giorgi U, Caroli P, Burgio SL, Menna C, Conteduca V, Bianchi E, Fabbri F, Carretta E, Amadori D, Paganelli G, Matteucci F. De Giorgi U, et al. Among authors: bianchi e. Oncotarget. 2014 Dec 15;5(23):12448-58. doi: 10.18632/oncotarget.2558. Oncotarget. 2014. PMID: 25504434 Free PMC article. Clinical Trial.

6

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

Conteduca V, Caffo O, Lolli C, Aieta M, Scarpi E, Bianchi E, Maines F, Schepisi G, Salvi S, Massari F, Carrozza F, Veccia A, Chiuri VE, Campadelli E, Facchini G, De Giorgi U. Conteduca V, et al. Among authors: bianchi e. Prostate. 2017 Jun;77(9):1012-1019. doi: 10.1002/pros.23357. Epub 2017 Apr 20. Prostate. 2017. PMID: 28429372

7

Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Caroli P, De Giorgi U, Scarpi E, Fantini L, Moretti A, Galassi R, Celli M, Conteduca V, Rossi L, Bianchi E, Paganelli G, Matteucci F. Caroli P, et al. Among authors: bianchi e. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):348-354. doi: 10.1007/s00259-017-3866-2. Epub 2017 Nov 6. Eur J Nucl Med Mol Imaging. 2018. PMID: 29110067 Clinical Trial.

8

High neutrophil-to-lymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer.

Rossi L, Santoni M, Crabb SJ, Scarpi E, Burattini L, Chau C, Bianchi E, Savini A, Burgio SL, Conti A, Conteduca V, Cascinu S, De Giorgi U. Rossi L, et al. Among authors: bianchi e. Ann Surg Oncol. 2015 Apr;22(4):1377-84. doi: 10.1245/s10434-014-4097-4. Epub 2014 Sep 19. Ann Surg Oncol. 2015. PMID: 25234022

9

The emerging role of anti-angiogenic therapy in ovarian cancer (review).

Conteduca V, Kopf B, Burgio SL, Bianchi E, Amadori D, De Giorgi U. Conteduca V, et al. Among authors: bianchi e. Int J Oncol. 2014 May;44(5):1417-24. doi: 10.3892/ijo.2014.2334. Epub 2014 Mar 10. Int J Oncol. 2014. PMID: 24626312 Review.

10

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

Lolli C, Caffo O, Scarpi E, Aieta M, Conteduca V, Maines F, Bianchi E, Massari F, Veccia A, Chiuri VE, Facchini G, De Giorgi U. Lolli C, et al. Among authors: bianchi e. Front Pharmacol. 2016 Oct 13;7:376. doi: 10.3389/fphar.2016.00376. eCollection 2016. Front Pharmacol. 2016. PMID: 27790145 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

904 results

Search Page

Filters